@WIRED 11 months ago
With new discussions around appetite-inhibitor medicines like Ozempic, it’s an interesting time to be the new CEO of WW, a service that, despite its millions of satisfied subscribers, has hoards of critics calling its points-based system the epitome of unhealthy diet culture. 6/8 https://t.co/fYX7GVIBwy
@WIRED 11 months ago
With new discussions around appetite-inhibitor medicines like Ozempic, it’s an interesting time to be the new CEO of WW, a service that, despite its millions of satisfied subscribers, has hoards of critics calling its points-based system the epitome of unhealthy diet culture. 6/8 https://t.co/18YBq1r5gO
@tech.eu 1 year ago
Amadeus Capital Partners’ Volker Hirsch joins Medicines Discovery Catapult as Chief Commercial Officer